ES2460040T3 - Procedimientos de síntesis y aislamiento de N-(bromoacetil)-3,3-dinitroazetidina y una composición que incluye la misma - Google Patents

Procedimientos de síntesis y aislamiento de N-(bromoacetil)-3,3-dinitroazetidina y una composición que incluye la misma Download PDF

Info

Publication number
ES2460040T3
ES2460040T3 ES11700989.4T ES11700989T ES2460040T3 ES 2460040 T3 ES2460040 T3 ES 2460040T3 ES 11700989 T ES11700989 T ES 11700989T ES 2460040 T3 ES2460040 T3 ES 2460040T3
Authority
ES
Spain
Prior art keywords
abdnaz
solvent
dnaz
dichloromethane
reaction mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11700989.4T
Other languages
English (en)
Spanish (es)
Inventor
Nicholas A. Straessler
Louis F. Cannizzo
Ping Li
Michael P. Kramer
David M. Rosenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northrop Grumman Innovation Systems LLC
Original Assignee
Alliant Techsystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliant Techsystems Inc filed Critical Alliant Techsystems Inc
Application granted granted Critical
Publication of ES2460040T3 publication Critical patent/ES2460040T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES11700989.4T 2010-02-09 2011-01-18 Procedimientos de síntesis y aislamiento de N-(bromoacetil)-3,3-dinitroazetidina y una composición que incluye la misma Active ES2460040T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US702782 1996-08-23
US12/702,782 US8471041B2 (en) 2010-02-09 2010-02-09 Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
PCT/US2011/021500 WO2011100090A1 (en) 2010-02-09 2011-01-18 Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same

Publications (1)

Publication Number Publication Date
ES2460040T3 true ES2460040T3 (es) 2014-05-13

Family

ID=43875262

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11700989.4T Active ES2460040T3 (es) 2010-02-09 2011-01-18 Procedimientos de síntesis y aislamiento de N-(bromoacetil)-3,3-dinitroazetidina y una composición que incluye la misma

Country Status (12)

Country Link
US (1) US8471041B2 (cg-RX-API-DMAC7.html)
EP (1) EP2534131B1 (cg-RX-API-DMAC7.html)
JP (1) JP5461712B2 (cg-RX-API-DMAC7.html)
KR (1) KR101456438B1 (cg-RX-API-DMAC7.html)
CN (1) CN102762535B (cg-RX-API-DMAC7.html)
AU (1) AU2011216176B2 (cg-RX-API-DMAC7.html)
CA (1) CA2788459C (cg-RX-API-DMAC7.html)
DK (1) DK2534131T3 (cg-RX-API-DMAC7.html)
ES (1) ES2460040T3 (cg-RX-API-DMAC7.html)
IL (1) IL221141A (cg-RX-API-DMAC7.html)
MX (1) MX2012008989A (cg-RX-API-DMAC7.html)
WO (1) WO2011100090A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070135380A1 (en) 2005-08-12 2007-06-14 Radiorx, Inc. O-nitro compounds, pharmaceutical compositions thereof and uses thereof
US7507842B2 (en) 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
US8664247B2 (en) 2011-08-26 2014-03-04 Radiorx, Inc. Acyclic organonitro compounds for use in treating cancer
US20140308260A1 (en) 2011-10-07 2014-10-16 Radiorx, Inc. Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
ES2935573T3 (es) 2011-10-07 2023-03-08 Epicentrx Inc Compuestos de organonitro tioéter y usos médicos de estos
US10342778B1 (en) 2015-10-20 2019-07-09 Epicentrx, Inc. Treatment of brain metastases using organonitro compound combination therapy
US9987270B1 (en) 2015-10-29 2018-06-05 Epicentrix, Inc. Treatment of gliomas using organonitro compound combination therapy
KR20190040931A (ko) 2016-01-11 2019-04-19 에피센트알엑스, 인코포레이티드 2-브로모-1-(3,3-디니트로아제티딘-1-일)에타논의 정맥내 투여를 위한 조성물 및 방법
EP3526195A4 (en) 2016-10-14 2020-05-20 EpicentRx, Inc. SULFOXYALKYLE ORGANONITRO, RELATED COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR USE IN MEDICINE
IL271777B2 (en) 2017-07-07 2024-09-01 Epicentrx Inc Compositions for parenteral administration of therapeutic agents
US11510901B2 (en) 2018-01-08 2022-11-29 Epicentrx, Inc. Methods and compositions utilizing RRx-001 combination therapy for radioprotection
MX2023014676A (es) * 2021-06-09 2024-02-06 Epicentrx Inc Composiciones de abdnaz cristalinas y metodos de elaboracion y uso de estas.
WO2024145484A1 (en) 2022-12-29 2024-07-04 Epicentrx, Inc. Rrx-001 for treating reproductive-related disorders

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4935450A (en) 1982-09-17 1990-06-19 Therapeutical Systems Corporation Cancer therapy system for effecting oncolysis of malignant neoplasms
JPS60116642A (ja) 1983-11-29 1985-06-24 Nippon Kayaku Co Ltd ２−モノ−置換メチル−５，５−ジメチル−シクロ−２−ヘキセノン誘導体
GB8504253D0 (en) * 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
GB8728418D0 (en) * 1987-12-04 1988-01-13 Jenkins T C Nitro-substituted aromatic/hetero-aromatic compounds for use in cancer treatment
DE3815221C2 (de) * 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
US5693794A (en) * 1988-09-30 1997-12-02 The United States Of America As Represented By The Secretary Of The Navy Caged polynitramine compound
JP2659614B2 (ja) * 1990-11-13 1997-09-30 株式会社日立製作所 表示制御装置
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5336784A (en) * 1993-06-07 1994-08-09 The Regents Of The University Of California Synthesis of 1,3,3-trinitroazetidine
ES2092460T3 (es) 1994-05-27 2001-02-01 Cellegy Pharma Inc Composicion dadora de oxido nitrico para el tratamiento de trastornos anales.
ES2177771T3 (es) * 1995-03-14 2002-12-16 Siemens Ag Dispositivo atomizador ultrasonico con unidad desmontable de dosificacion de precision.
NZ304009A (en) * 1995-03-14 1999-02-25 Siemens Ag Ultrasonic atomizer device with a removable precision dosating unit
US5580988A (en) * 1995-05-15 1996-12-03 The United States Of America As Represented By The Secretary Of The Army Substituted azetidines and processes of using them
AU5798996A (en) 1995-05-15 1996-11-29 Sachs, Michael C. Adnaz, compositions and processes
US5898038A (en) * 1996-03-19 1999-04-27 Board Of Regents, The University Of Texas System Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors
AU3129097A (en) 1996-10-15 1998-05-11 Eastman Chemical Company Explosive formulations
GB9720797D0 (en) 1997-09-30 1997-12-03 Rhodes John Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
US5954047A (en) * 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
US6056966A (en) * 1998-05-18 2000-05-02 Baker Norton Pharmaceuticals, Inc. Method and compositions for treating impotence
AU750313B2 (en) 1998-07-27 2002-07-18 St. Jude Pharmaceuticals, Inc. Chemically induced intracellular hyperthermia
US6448253B1 (en) * 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
US6245799B1 (en) * 1999-11-08 2001-06-12 American Home Products Corp [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders
HRP20020808A2 (en) 2000-04-10 2004-12-31 Pfizer Prod Inc Benzoamide piperidine containing compounds and related compounds
US6861530B2 (en) * 2000-07-07 2005-03-01 Kyowa Hakko Kogyo Co., Ltd. Piperidine derivatives
DE10111049A1 (de) 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen, zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut
EP1336602A1 (en) 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
AU2003247792B2 (en) * 2002-07-03 2009-09-24 Nicox S.A. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
AU2003282534A1 (en) * 2002-10-07 2004-05-04 Radiorx, Inc. X-nitro compounds, pharmaceutical compositions thereof and uses therof
US6870061B2 (en) * 2003-01-10 2005-03-22 Alliant Techsystems Inc. Continuous process and system for production of glycidyl nitrate from glycerin, nitric acid and caustic and conversion of glycidyl nitrate to poly(glycidyl nitrate)
AU2004237574A1 (en) 2003-03-13 2004-11-18 Nitromed, Inc. Nitrosated and nitrosylated compounds, compositions and methods of use
EP1646608B1 (en) 2003-06-25 2011-03-02 JE IL Pharmaceutical Co., Ltd. Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
GB0326047D0 (en) 2003-11-07 2003-12-10 Univ Sheffield Substance
JP2008512490A (ja) * 2004-09-08 2008-04-24 チェルシー・セラピューティクス，インコーポレイテッド 異常細胞増殖および炎症の障害を治療するための代謝的に不活性な葉酸拮抗剤
US7507842B2 (en) * 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
US20070135380A1 (en) 2005-08-12 2007-06-14 Radiorx, Inc. O-nitro compounds, pharmaceutical compositions thereof and uses thereof
BRPI0616755A2 (pt) * 2005-09-27 2011-06-28 Novartis Ag compostos de carboxiamina e métodos de uso dos mesmos
KR100967848B1 (ko) * 2008-05-28 2010-07-05 국방과학연구소 분자화약이 도입된, 고에너지 결합제용1-글리시딜-3,3-디니트로아제티딘 및 그의 제조방법
WO2012078992A1 (en) * 2010-12-09 2012-06-14 Radiorx, Inc. Organonitro compounds for use in treating non-hodgkin's lymphoma and leukemia, and methods relating thereto

Also Published As

Publication number Publication date
KR101456438B1 (ko) 2014-10-31
AU2011216176A1 (en) 2012-08-23
CN102762535B (zh) 2014-09-03
EP2534131A1 (en) 2012-12-19
MX2012008989A (es) 2012-08-23
IL221141A0 (en) 2012-09-24
IL221141A (en) 2016-08-31
CA2788459A1 (en) 2011-08-18
JP2013518925A (ja) 2013-05-23
JP5461712B2 (ja) 2014-04-02
DK2534131T3 (da) 2014-04-07
WO2011100090A1 (en) 2011-08-18
CA2788459C (en) 2016-01-05
AU2011216176B2 (en) 2013-11-14
US20110195947A1 (en) 2011-08-11
EP2534131B1 (en) 2014-03-19
US8471041B2 (en) 2013-06-25
CN102762535A (zh) 2012-10-31
KR20130053385A (ko) 2013-05-23

Similar Documents

Publication Publication Date Title
ES2460040T3 (es) Procedimientos de síntesis y aislamiento de N-(bromoacetil)-3,3-dinitroazetidina y una composición que incluye la misma
ES2384652T3 (es) Sales de escopina y su utilización en procedimientos para la preparación de N-demetil-tiotropio y bromuro de tiotropio
JP2014524920A5 (cg-RX-API-DMAC7.html)
EP3481200B1 (en) Processes for the preparation of 4-alkoxy-3-(acyl or alkyl)oxypicolinamides
CA2882119A1 (en) Solid forms of an antiviral compound
EP3490973B1 (en) Polymorphic forms of belinostat and processes for preparation thereof
ES2991081T3 (es) Procedimiento para preparar 2-(3,5-diclorofenil)-6-benzoxazolcarboxilato de 1-desoxi-1-metilamino-D-glucitol
JP2016145214A (ja) 集中的還元的アミノ化によるフェロキンの合成方法
ES2619403T3 (es) Proceso para producir lacosamida
US20210395197A1 (en) Crystalline form of sofpironium bromide and preparation method thereof
ES2436800T3 (es) Derivados ferrocénicos con actividad anticancerosa
CN107674062B (zh) 抗丙肝药物中间体、制备方法及应用
JP2019534299A (ja) （ｓ）−ｎ１−（２−アミノエチル）−３−（４−アルコキシフェニル）プロパン−１，２−ジアミン三塩酸塩の製造方法
ES2741505T3 (es) Procedimiento para la preparación de acetato de abiraterona y sus productos intermedios
CN105745191A (zh) 一种西洛多辛及其中间体的制备方法
CN113072514B (zh) 轮环藤宁及其中间体的制备方法
ES2984183T3 (es) Proceso para preparar derivados de anfetamina acilados
CN119059990B (zh) 1-氨基甲酸叔丁酯哌嗪的制备方法
ES2318285T3 (es) Procedimiento para la preparacionb de 3-oxoglutaratos de dialquilo.
JP2019131532A (ja) 酸無水物、および該酸無水物を用いたｌ−カルノシンの製造方法
CN103172557A (zh) 具有胆碱转运体亲和力的靶向功能分子
JP2815438B2 (ja) １，２―ビス（ニコチンアミド）プロパンの精製方法
CN114671836A (zh) 一种胺碘酮杂质c的合成方法
CN102137840A (zh) 加巴喷丁酯盐及其制备方法
ITPD20080215A1 (it) Metodo di preparazione di alfuzosin cloridrato anidro